A high prevalence of single immune markers, such as FOXP3, can lead to PDAC progression and poor prognosis, but given that the immune system plays both anti- and pro-tumorigenic roles, immune modulations of the tumor microenvironment involving immunoactive and immunosuppressive molecules should not be neglected [13]. The gene discussed is FOXP3; the disease is neoplasm.